- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Latest Conference Articles
A Discussion on Using AI in R&D at the US Pharma and Biotech Summit
May 18th 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.
A Look at the Future of Bio/Pharma Partnerships at the US Pharma and Biotech Summit
May 17th 2024
Ken Keller, president and CEO, Daiichi Sankyo, discusses the foundation of partnership and takes a look at the future of biotech partnerships at the US Pharma and Biotech Summit.
How TekniPlex is Expanding to Support Innovative Solutions in Materials Science
May 17th 2024
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.
Federal Equipment Company: Supporting CDMO Operations Through Training, Parts, and Equipment
May 13th 2024
Adam Covitt, President of Federal Equipment Company, discusses how the company enables CDMO successes with its Techceuticals and PharmParts business brands.
Research Shows that HIC Can Effectively Separate Deaminated Capsids from Non-Deaminated Capsids (ASGCT 2024)
May 11th 2024
The separation of deamidated capsids from non-deamidated capsids can be achieved using HIC, according to studies done by a team at Oxford Biomedica.
Using Receptor Architecture to Improve CAR-T Cell Sensitivity in Oncology (ASGCT 2024)
May 11th 2024
Phillip Gregory, PhD, senior vice-president and head of Regeneron Cell Medicines, Regeneron, discussed how engineering receptor architecture can be a tool to improve CAR-T cell sensitivity to tumor antigens.
The Role of Bispecific Antibodies in Redirecting AAV Vectors (ASGCT 2024)
May 11th 2024
Regeneron's Sven Moller-Tank, PhD, director of Viral Delivery Technologies, Regeneron Genetic Medicines, discusses the company's work in using bispecific antibodies for redirecting AAV target specificity.
Embedding Sustainability in Drug Delivery through Industry Consensus at CPHI NA
May 10th 2024
At CPHI NA, Rachel Harris, AstraZeneca, spoke on her work at BioPhorum to enable industry consensus and action for sustainability with drug delivery devices.
CPHI North America: Industry Trends, Agenda Additions, and What to Expect at CPHI Milan
May 9th 2024
Tara Dougal, content director, Pharma, Informa Markets, discusses successes and insights from this year’s CPHI North America and the agenda for the upcoming CPHI Milan.
Interpreting Regulations and Meeting FDA Requirements at CPHI North America
May 9th 2024
Purna Thakker, founder and CEO of ADPT Solution, discusses common issues that companies face with FDA regulations at CPHI North America.